abbvie dividend yield

Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Dividend Aristocrat AbbVie Declares Its Latest Payout; Yield Is 5.3% The company is one of the most solid dividend dispensers in its industry. Click the "+Follow" next to my byline to this article. Real Money's message boards are strictly for the open exchange of investment ideas among registered users. While debt levels are now elevated in comparison to the firm's competitors, cash flow has in my view been protected. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Thank you for your cooperation. That’s fairly competitive among the company’s peers in the pharmaceutical industry. Revenue also beat, while showing better than 10% annual growth. Delayed quotes by Sungard.

(AbbVie, Abbott Labs and Johnson & Johnson are holdings in Jim Cramer's Action Alerts PLUS member club.

Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. If you have questions, please contact us.

Best sellers? ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. It can be tempting to try to predict when the bears will eventually gain some traction, but here's what to do instead. ETF data provided by Lipper. Do J&J's Q3 Results Indicate a Sales Recovery for Big Pharma? Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Learn more about Zacks Equity Research reports. ZacksTrade and Zacks.com are separate companies. The data does update after 90 days if no rating change occurs within that time period. The partnership with I-Mab represents a branching out and, it seems, a reduction in dependence on Humira. The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. Perhaps that’s because AbbVie stock tends to get pigeonholed as a Big Pharma bet. Please contact customer support to let us know. Earnings and ratings provided by Zacks.

Some AbbVie stock holders have been calling for the company to expand its pipeline for quite a while. That same day, the firm finally received FTC (Federal Trade Commission) clearance to proceed with the Allergan deal, of course there was some hair on the approval, but that was largely expected. A major moneymaker for AbbVie, Humira is designed to treat Crohn’s disease, ulcerative colitis, psoriasis, multiple forms of arthritis and other conditions.

AbbVie (ABBV) Stock Moves -0.55%: What You Should Know, 5 High-Yield Stocks for 5%-Plus Dividend Payouts, 7 Value Stocks To Buy in an Overvalued Market, Remdesivir didn`t reduce mortality among COVID-19 in WHO study: Report, Buy AbbVie Before It Raises Dividends Again, Gilead: Incredible Antivirals, Risky Drug Lineup.

The steady dividend distributions provide a strong incentive to own AbbVie stock. Then again, the stock is a different animal going forward from here. Growth was still good in the U.S., however, where the similar patent does not expire until 2023. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.